Menu
NASP

All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

Learn about treatment options, treatment failure, associated adverse effects and more.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

SHOW SEARCH

Certification in Specialty Pharmacy Exam - Preparation Course

Activity Downloads

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.

This activity is available for $149 to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.
A product of the National Association of Specialty Pharmacy's (NASP) Center for Specialty Pharmacy Education (CSPE) 

 
 View more NASP/CSPE Activities
 

Activity Description

Specialty pharmacy is the fastest growing segment of pharmacy practice today and will continue for the foreseeable future. Specialty pharmacy impacts only a small percent of the population; however, the diseases and drug therapies are very complex and require a higher level of knowledge compared to more traditional diseases and drug therapies. The Certified Specialty Pharmacist Credential is designed to validate your professional expertise, elevate the status of the specialty pharmacy profession, differentiate yourself in a competitive job market, position yourself for handling limited or exclusively distributed drugs, position yourself to better serve payer requirements, and protect the public by improving their health outcomes and reducing medication errors.

The CSP Exam Preparatory Course will cover aspects of Clinical, Fulfillment, Intake and Outcomes that might be expected on the exam. Join expert faculty as key aspects of specialty pharmacy and the specialty pharmacist’s role are discussed. Key topics include the fundamentals and considerations for the patient intake process, as well as fulfillment workflows, quality assurance and dispensing channels. Outcomes measures and standards are covered, and clinical modules review persistence and adherence, specialty drug classes, indications, interactions, and more.

Learning Objectives

The target audience for this activity includes pharmacists.

Part 1 covers the following modules:
Operations Module: Intake, Clinical Management, Outcomes & Fulfillment – Mel Nelson, Rushabh Shah
Inflammatory Diseases – April Jones
Osteoporosis – Kevn McNamara
Oncology – Marcy Snell
Transplant, Infertility – Marcy Snell

At the completion of Part 1, participants will be able to:
  • Discuss the pharmacotherapy of the specialty medications used to treat inflammatory diseases (including gastrointestinal, dermatological and rheumatological disorders).
  • Review the pharmacotherapy of specialty oncology medications.
  • List the fundamental steps of the patient intake, reimbursement, fulfillment and outcomes process for specialty patients.
  • Outline the medication management processes for the specialty pharmacy.
  • Review the pharmacotherapy of medications used in the treatment of solid organ transplantation.
  • Discuss the pharmacotherapy of the medications used in the treatment of solid organ infertility.
 
Part 2
covers the following modules:
Multiple Sclerosis & Neurological Conditions – Selina Mullins
HepC, HIV, CF – Kristen Whelchel
PAH & Cardiology, RSV, Growth Hormone – Kevn McNamara
Immunoglobulins, Hemophilia – Erin Mellerski

At the completion of Part 2, participants will be able to:
  • Review the pharmacotherapy of the specialty medications used to treat Multiple Sclerosis and other neurological disorders.
  • Discuss the pharmacotherapy of the specialty medications used to treat HIV, Hepatitis C and Cystic Fibrosis.
  • Describe specialty medications used in the treatment of Osteoporosis.
  • Review the pharmacotherapy of the specialty medications used for hemophilia and immune deficiency disorders.
  • Discuss the pharmacotherapy of the specialty medications used to treat Pulmonary Arterial Hypertension, Hypercholesterolemia, Growth Hormone Deficiency and RSV.

Faculty

Brenda L. Gray, PharmD, CNSC, BCNSP, VA-BC, PRS, CVAA(c)
Owner and Senior Pharmacist Consultant
Clinical Pharmacy Partners

Mel Nelson, PharmD, CSP
Specialty Pharmacy Manager
Fairview Pharmacy Services

April J. Jones, PharmD, CSP
Clinical Specialty Pharmacist
Vanderbilt Specialty Pharmacy

Rushabh Shah, PharmD, MBA, AAHIVP, CSP
Associate Director
University of Kentucky Specialty Pharmacy

Kevn M. McNamara, PharmD, CPS, CNSC, PRS, CVAA(c)
Owner and Senior Consultant
Clinical Pharmacy Partners

Marcy Snell, PharmD, CSP
Coordinator of Oncology Services
Henry Ford Pharmacy Advantage

Erin Stack Mellerski, PharmD, CSP
Director of Pharmacy Operations
Supervising Pharmacist
Cottrill’s Specialty Pharmacy

Selina Mullins, PharmD, MBA
Clinical Specialty Pharmacist
University of Kentucky

Kristen Whelchel, PharmD
Clinical Pharmacist
Vanderbilt Specialty Pharmacy

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. None of the speakers have any relevant commercial or financial relationships to disclose.

Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.

CE Accreditation

Release Date: 11-15-2019
Expiration Date: 11-15-2022

Pharmacists

This CE activity is jointly provided by ProCE, Inc. and NASP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Numbers 0221-9999-19-526-H04-P and 0221-9999-19-527-H04-P have been assigned to these knowledge-based home-study CE activities (initial release date 11-15-19). These activities (2 individual activities) are approved for a maximum of 7.6 total contact hours (0.76 CEU) in states that recognize ACPE providers. Completion of the evaluations and the post-tests with a score of 70% or higher are required to receive CE credit. No partial credit will be given.

Funding

No external support has been received for this activity.

The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.